In 2017, a PET study performed in human carriers of a mutation in the gene LRRK2 associated with PD demonstrated, for the first time, an alteration in SERT binding in the striatum when compared to control subjects before the onset of motor symptoms [11]. The gene discussed is LRRK2; the disease is Parkinson disease.